Axsome Therapeutics (AXSM) EBITDA margin US GAAP (year values)

2020 2021 2022 2022 2023   LTM ? CAGR 5 years ?
EBITDA margin, % ? -348.2% -83.1%   -88.8%  
Changes by years, y/y, % +265pp     -76.1%

Axsome Therapeutics. EBITDA margin, %

Created with Highcharts 6.0.6-348.2-348.2-83.1-83.1-88.8-88.820222023LTM-400-350-300-250-200-150-100-500smart-lab.ru

Axsome Therapeutics. EBITDA margin, changes, pp

Created with Highcharts 6.0.6265.1265.1-5.7-5.72023LTM-50050100150200250300smart-lab.ru

Axsome Therapeutics (AXSM) EBITDA margin US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
EBITDA margin, % ? -104.5% -135.0% -87.3% -89.5% -57.8%   -88.8%
Changes by years, y/y, % +136pp +85pp -82pp +33pp +47pp    
Changes by quarters, q/q, % +18pp -30pp +48pp -2pp +32pp    

Axsome Therapeutics. EBITDA margin, %

Created with Highcharts 6.0.6-429.8-429.8-439.6-439.6-240.4-240.4-220.3-220.3-5.2-5.2-122.9-122.9-104.5-104.5-135.0-135.0-87.3-87.3-89.5-89.5-57.8-57.82022Q22022Q22022Q32022Q42022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q3-500-400-300-200-1000smart-lab.ru

Axsome Therapeutics. EBITDA margin, changes, pp

Created with Highcharts 6.0.6316.6316.6135.9135.985.485.4-82.0-82.033.433.446.746.72023Q22023Q32023Q42024Q12024Q22024Q3-200-1000100200300400smart-lab.ru

Axsome Therapeutics. EBITDA margin, changes, pp

Created with Highcharts 6.0.6-9.8-9.8199.2199.2240.4240.4215.1215.1-117.7-117.718.518.5-30.5-30.547.747.7-2.3-2.331.731.72022Q22022Q32022Q42022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q3-200-1000100200300smart-lab.ru